|     |   |                                                                                   |
|----------|--------|----------------------------------------------------------------------------------------|
| ☑ |   | QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIESEXCHANGE ACT OF 1934 |

|     |   |                                                                                    |
|----------|--------|-----------------------------------------------------------------------------------------|
| ☐ |   | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIESEXCHANGE ACT OF 1934 |

|                                                          |   |                                |
|---------------------------------------------------------------|--------|-------------------------------------|
|                                                          |   |
| Nevada                                                        |   | 20-5093315                          |
| (State or other jurisdiction ofincorporation or organization) |   | (I.R.S. EmployerIdentification No.) |

|                   |           |
|------------------------|----------------|
| Largeaccelerated filer |  [ ] | Acceleratedfiler | [ ] |
| Non-Acceleratedfiler   |  [ ] | Smallerreporting company | [X] |
|                   |           | Emerginggrowth company | [ ] |

 

| Exhibit   |   |                                                                                                                                                                                                                                                    |
|-----------|--------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Number    |   | Description                                                                                                                                                                                                                                             |
|      |   |                                                                                                                                                                                                                                                    |
| 10.1+**   |   | LicenseAgreement (PH94B), by and between VistaGen Therapeutics, Inc. andPherin Pharmaceuticals, Inc., dated September 11, 2018,incorporated by reference from Exhibit 10.1 to the Company’sCurrent Report on Form 8-K filed on September 13,2018 |
|      |   |                                                                                                                                                                                                                                                    |
| 10.2+**   |   | OptionAgreement, by and between VistaGen Therapeutics, Inc. and PherinPharmaceuticals, Inc., dated September 11, 2018, incorporated byreference from Exhibit 10.2 to the Company’s Current Reporton Form 8-K filed on September 13, 2018         |
|      |   |                                                                                                                                                                                                                                                    |
| 10.3*     |   | LicenseAgreement (PH10), by and between VistaGen Therapeutics, Inc. andPherin Pharmaceuticals, Inc., dated October 24, 2018, filedherewith.                                                                                                             |
|      |   |                                                                                                                                                                                                                                                    |
| 10.4**    |   | Form of Fall2018 Private Placement Subscription Agreement.                                                                                                                                                                                              |
|      |   |                                                                                                                                                                                                                                                    |
| 10.5**    |   | Form of Fall2018 Private Placement Warrant.                                                                                                                                                                                                             |
|      |   |                                                                                                                                                                                                                                                    |
| 31.1**    |   | Certificationof the Principal Executive Officer required by Rule 13a-14(a)under the Securities Exchange Act of 1934, as amended, as adoptedpursuant to Section 302 of the Sarbanes-Oxley Act of2002                                           |
|      |   |                                                                                                                                                                                                                                                    |
| 31.2**    |   | Certificationof the Principal Financial Officer required by Rule 13a-14(a)under the Securities Exchange Act of 1934, as amended, as adoptedpursuant to Section 302 of the Sarbanes-Oxley Act of2002                                           |
|      |   |                                                                                                                                                                                                                                                    |
| 32**      |   | Certificationof the Principal Executive and Financial Officers required byRule 13a-14(b) and Section 1350 of Chapter 63 ofTitle 18 of the United States Code, as adopted pursuant toSection 906 of the Sarbanes-Oxley Act of2002    |
|      |   |                                                                                                                                                                                                                                                    |
| 101.INS** |   | XBRLInstance Document                                                                                                                                                                                                                                   |
| 101.SCH** |   | XBRLTaxonomy Extension Schema                                                                                                                                                                                                                           |
| 101.CAL** |   | XBRLTaxonomy Extension Calculation Linkbase                                                                                                                                                                                                             |
| 101.DEF** |   | XBRLTaxonomy Extension Definition Linkbase                                                                                                                                                                                                              |
| 101.LAB** |   | XBRLTaxonomy Extension Label Linkbase                                                                                                                                                                                                                   |
| 101.PRE** |   | XBRLTaxonomy Extension Presentation Linkbase                                                                                                                                                                                                            |

S

|   |                                                                                                                            |   |   |   |
|--------|---------------------------------------------------------------------------------------------------------------------------------|--------|--------|--------|
|   | VISTAGENTHERAPEUTICS, INC.  /s/Shawn K. SinghShawnK. SinghChief Executive Officer (Principal Executive Officer)  |   |
|   | /s/Jerrold D. Dotson                                                                                                            |   |
|   | JerroldD. Dotson                                                                                                                |   |
|   | Chief Financial Officer (Principal Financial and AccountingOfficer)                                                             |   |